Skip to content
  • +44 (0) 1302 986 088
  • hello@adactmedical.com
  • ISO: 17025
  • +44 (0) 1302 986 088
  • hello@adactmedical.com
Twitter Instagram Facebook-f Linkedin-in
  • About
    • About Damien
  • Services
    • Regulatory Compliance
      • Cannabinoid (CBD)
      • TPD
    • Analytical Testing
    • Support Resources
      • TPD.Expert
        • Disposables Checklist
        • Shortfills Checklist
        • Nicotine Range Checklist
      • TPD by Country
      • Vape Safe
  • CBD
  • TPD
  • News
  • Calendar
  • Contact
Menu
  • About
    • About Damien
  • Services
    • Regulatory Compliance
      • Cannabinoid (CBD)
      • TPD
    • Analytical Testing
    • Support Resources
      • TPD.Expert
        • Disposables Checklist
        • Shortfills Checklist
        • Nicotine Range Checklist
      • TPD by Country
      • Vape Safe
  • CBD
  • TPD
  • News
  • Calendar
  • Contact
£0.00 Basket
  • Login
  • Register
  • Track my Order

New fee changes for Italy

New fee changes for Italy

The Decree of 7 March 2022 published in the Official Gazette introduced in Italy:
• the cost of notification of electronic cigarettes and refill liquids equal to 327.85 € per product;
• the cost of updates or corrections to e-cigarette and refill liquid notifications equal to 108.03 € per product.

These newly introduced tariffs are considered retroactive for products currently on the market. There are also annual costs, the amount of which is the subject of a request for clarification to the Ministry.

ADACT recommend any customers with products currently listed for sale in Italy which are not currently being sold there to contact us to discuss removing notifications, if they so wish.

To discuss the regulatory compliance and testing involved when selling your products in Italy, please call +44(0)1302 986 088 or email hello@adactmedical.com

Share:

More Posts

ADACT awarded controlled drugs license for analysing and testing CBD

ADACT awarded controlled drugs license for analysing and testing CBD

We’re delighted to announce that ADACT Medical has been granted

Get in front of the market with Disposables Performance Testing and Certification

Get in front of the market with Disposables Performance Testing and Certification

With the increased scrutiny on disposable products from Trading Standards,

Sweden agrees vape flavour ban for 2023

Sweden agrees vape flavour ban for 2023

Despite being seen as a ’smokefree success’ after a 2017

Your guide to compliant retailing of disposable vape products

The UK Vaping Industry Association (UKVIA) guide to compliant retailing

PrevPreviousGet in front of the market with Disposables Performance Testing and Certification
NextADACT awarded controlled drugs license for analysing and testing CBDNext

Related News

ADACT awarded controlled drugs license for analysing and testing CBD
June 27, 2022

ADACT awarded controlled drugs license for analysing and

We’re delighted to announce that ADACT Medical has been granted a controlled drugs

More details
New fee changes for Italy
June 14, 2022

New fee changes for Italy

The Decree of 7 March 2022 published in the Official Gazette introduced in

More details
Get in front of the market with Disposables Performance Testing and Certification
May 19, 2022

Get in front of the market with Disposables

With the increased scrutiny on disposable products from Trading Standards, regulators and the

More details
ADACT leading regulatory compliance specialists with cutting edge analytical testing.

Services

  • Regulatory Compliance
  • Analytical Testing
  • Support Resources
Menu
  • Regulatory Compliance
  • Analytical Testing
  • Support Resources

Company

  • About
  • Contact
  • News
  • Calendar
Menu
  • About
  • Contact
  • News
  • Calendar

Others

  • Login
  • Register
  • Track my Order
Menu
  • Login
  • Register
  • Track my Order

GDPR

  • Privacy Settings Page
  • Terms & Conditions
  • Privacy Policy
  • Shipping Policy
Menu
  • Privacy Settings Page
  • Terms & Conditions
  • Privacy Policy
  • Shipping Policy

Copyright © ADACT Medical Ltd 2022 All rights reserved